Clinique Pasteur Toulouse
12
4
4
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
SpaceOAR Post-Market Registry Study
Role: collaborator
Enhanced Valves Interventions and Safe AI Generated End Results
Role: collaborator
French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR
Role: collaborator
Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
Role: collaborator
French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV
Role: collaborator
Intravascular Lithotripsy in Comparison to Rotational Atherectomy: An Evaluation by OFDI
Role: collaborator
S-ICD French Cohort Study (HONEST)
Role: collaborator
Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle
Role: collaborator
Catheter Ablation in Congenital Heart Disease: French National Prospective Registry
Role: collaborator
Prospective Evaluation of Programmed Ventricular Stimulation Before Pulmonary Valve Replacement in Patients With Tetralogy of Fallot
Role: collaborator
Left Atrial Appendage Occlusion Guided by 3D Printing
Role: collaborator
Primary Prevention ICD French Registry
Role: collaborator
All 12 trials loaded